Insider Transactions in Q2 2024 at Singular Genomics Systems, Inc. (OMIC)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,584
+0.35%
|
-
|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,584
-59.89%
|
-
|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,584
+37.46%
|
-
|
|
Jun 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.16%
|
-
|
|
Jun 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+2.71%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
57,188
+1.36%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
57,188
-85.41%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,188
+46.07%
|
-
|
|
May 09
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.33%
|
-
|
|
May 09
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.51%
|
-
|
|
May 09
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+41.67%
|
-
|